Current role
Nia Tatsis
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nia Tatsis
The proxy statement of Vertex Pharmaceuticals Inc / Ma reports total compensation of $6,974,920 for Nia Tatsis in fiscal 2025, including a base salary of $750,000. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Vertex Pharmaceuticals Inc / Ma (VRTX)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Vertex Pharmaceuticals Inc / Ma
Other people whose current roles at this company are on record from its filings.
- Dr. Reshma Kewalramani CEO
- Reshma Kewalramani CEO, Board Member
- Dr. Jeffrey M. Leiden Chairman
- Jeffrey Leiden Chairman, Board Member
- Charles Wagner CFO
- Jonathan Poole CFO
- Charles F. Wagner, Jr. COO
- Stuart Arbuckle COO
- Alan Garber Board Member
- Bruce Sachs Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vertex Pharmaceuticals Inc / Ma (VRTX) | EVP & Chief Regulatory and Quality Officer | $750,000 | $6,974,920 |
| 2024 | Vertex Pharmaceuticals Inc / Ma (VRTX) | EVP & Chief Regulatory and Quality Officer | $691,154 | $7,334,316 |
| 2021 | Vertex Pharmaceuticals Inc / Ma (VRTX) | EVP & Chief Regulatory and Quality Officer | $550,000 | $6,584,028 |
Recent activity
No call appearances or filed executive changes recorded yet.